Jaguar Health, Inc.

Jaguar Health will hold a Special Meeting of Stockholders on November 6, 2026, to vote on proposals including the issuance of common stock upon exchange of Series Q Preferred Stock and debt, repricing of investor warrants to $1.00, a reverse stock split at a ratio between 1-for-2 and 1-for-150, and reducing the floor price of an existing stock purchase agreement to $1.10. These measures are intended to optimize the company's capital structure and facilitate future financing flexibility.…more

Jaguar Health, Inc.

Jaguar Health has declared a special stock dividend of Series R Convertible Preferred Stock to holders of its common stock and certain warrants as of October 13, 2026. These preferred shares will automatically convert into five shares of common stock each on November 2, 2026, intended to provide dilution protection for existing shareholders. Additionally, the company entered into amendments to extend the maturity and payment initiation dates for existing royalty interests and a secured promissory note to January 1, 2027.…more